The NMPA released a public notice announcing newly accepted applications for the protection of Traditional Chinese Medicine (TCM) varieties. The update includes the acceptance of a renewal application for Compound Muniziqi Granules submitted by Xinjiang Uygur Pharmaceutical Co., Ltd. The notice reinforces China’s ongoing efforts to safeguard and regulate traditional medicinal preparations.

Key Highlights:

  • NMPA published a list of accepted applications for TCM variety protection
  • Includes a renewal application for Compound Muniziqi Granules
  • Notice issued through the National Government Service Platform
  • Supports structured protection of traditional formulations and associated market rights

This update enhances Regulatory clarity around TCM variety protection and lifecycle management.

Select Mandate HA
Select Mandate Function